sales@intentmarketresearch.com
+1 463-583-2713
As per Intent Market Research, the Poultry Diagnostics Market was valued at USD 740.5 million in 2023 and will surpass USD 1,035.5 million by 2030; growing at a CAGR of 4.9% during 2024 - 2030.
The poultry diagnostics market is a vital segment of the broader animal health industry, driven by the increasing need for accurate and timely disease detection in poultry. The growing demand for poultry products across the globe has led to intensified efforts in ensuring poultry health through diagnostic tools. The need for robust disease management systems to address outbreaks and safeguard both public health and animal welfare is pushing innovations in poultry diagnostics. With advances in testing technologies such as PCR, immunoassays, and lateral flow devices, the poultry diagnostics sector is evolving rapidly, offering a wide range of solutions to address both emerging and endemic diseases in poultry. The market is set to experience strong growth, fueled by innovations in diagnostic methodologies and rising awareness about poultry diseases.
Immunoassays are the largest and most widely adopted diagnostic technique in the poultry diagnostics market due to their affordability, speed, and reliability in detecting various poultry diseases. These tests are designed to identify specific proteins or antibodies that are present when a particular disease is active in the poultry population. Immunoassay technology, such as enzyme-linked immunosorbent assay (ELISA) and lateral flow assays, is preferred by veterinary professionals and poultry farms for their ease of use and quick results. Immunoassays are used extensively for detecting diseases like Avian Influenza, Salmonella, and Infectious Bronchitis. The cost-effectiveness and simplicity of immunoassays make them an attractive option for poultry farms across both developed and developing markets.
Immunoassay-based diagnostics are not only vital for disease management but also contribute significantly to biosecurity measures in poultry farming. Given the cost-sensitive nature of the poultry industry, especially in regions like Asia-Pacific and Latin America, immunoassay technology’s widespread accessibility and proven track record have made it the primary choice for large-scale poultry health management programs. With rapid advancements in immunoassay technologies, the segment is expected to maintain its dominance in the coming years, further benefiting from increased automation and higher sensitivity in newer assay kits.
Avian Influenza remains the largest disease segment in the poultry diagnostics market. The global poultry industry has long been plagued by periodic outbreaks of this disease, which leads to significant economic losses, disruptions in poultry supply chains, and public health concerns. Avian Influenza is a highly contagious viral disease that affects birds, especially poultry, and can cause high mortality rates among infected flocks. The growing number of outbreaks in countries with large poultry industries, such as the United States, China, and several European countries, has increased the demand for effective diagnostics and surveillance programs to contain the spread of the disease.
The importance of early detection and containment of Avian Influenza is critical in mitigating its impact on both the poultry industry and public health. Diagnostic tools such as PCR-based tests, serological tests, and immunoassays are essential in providing quick, accurate results for early intervention. The government and regulatory agencies globally have enforced stricter guidelines for poultry health monitoring, contributing to the growth of diagnostic services and technologies tailored to Avian Influenza. This disease segment is expected to continue driving the demand for diagnostic tools as the frequency of outbreaks increases with global trade and migration patterns.
The serological tests segment is the fastest growing in the poultry diagnostics market, primarily due to the continuous advancements in testing technology and its increasing adoption in disease surveillance. Serological tests detect antibodies that are produced by the immune system in response to pathogens such as viruses or bacteria. These tests are highly effective for large-scale screenings, and they play a crucial role in monitoring and identifying poultry diseases before they cause widespread outbreaks. With the increasing focus on preventive healthcare and the implementation of biosecurity measures, serological tests have gained popularity due to their ability to provide fast, reliable results at a lower cost compared to molecular diagnostic methods.
Technological innovations in serological testing, such as the development of more sensitive kits and the integration of digital platforms for real-time data reporting, are driving growth in this segment. These improvements allow for large-scale monitoring across poultry farms, helping prevent the spread of diseases like Salmonella, Coccidiosis, and Newcastle Disease. As more poultry farms and diagnostic laboratories shift toward preventive health measures and surveillance, the demand for serological tests is expected to increase rapidly in both developed and emerging markets.
Poultry farms are the largest end-users of poultry diagnostics, owing to the increasing emphasis on maintaining optimal flock health and preventing disease outbreaks. The demand for high-quality poultry products has led to higher investments in farm management practices, which includes regular health screening and disease monitoring. With the rising concern over disease outbreaks such as Avian Influenza and Salmonella, poultry farms across the globe are increasingly investing in diagnostic tools that can help detect diseases early and reduce the risk of contamination and economic losses. Regular diagnostics in poultry farms are becoming an integral part of biosecurity programs, particularly in industrial-scale operations where flocks can be large and the potential spread of diseases can have significant financial consequences.
Poultry farms also benefit from the advancements in point-of-care diagnostics that enable faster decision-making and reduce the time to intervention. The integration of these diagnostic tools into farm management systems allows for continuous monitoring of flock health, which is crucial in ensuring high productivity and minimizing disruptions. As the poultry industry continues to expand, particularly in emerging economies, the need for reliable and efficient diagnostics in farms is expected to drive further market growth.
The Asia Pacific region is experiencing the fastest growth in the poultry diagnostics market, driven by rapid increases in poultry production and consumption in countries such as China, India, and Southeast Asia. The region's growing population and increasing demand for poultry products are pushing the need for efficient disease management and diagnostics. Moreover, as the poultry industry in these countries modernizes and large-scale commercial farming becomes more widespread, there is an increasing focus on biosecurity measures and regular health monitoring to prevent outbreaks of avian diseases.
In countries like China and India, government initiatives, coupled with the rising awareness of poultry health, are accelerating the adoption of poultry diagnostics. The growth of the poultry diagnostics market in this region is further supported by rising investments in diagnostic technologies and research. With regulatory authorities pushing for more stringent poultry health management practices, the Asia Pacific region is poised to remain the fastest growing market for poultry diagnostics in the coming years.
The competitive landscape of the poultry diagnostics market is dominated by key players such as Zoetis Inc., IDEXX Laboratories, Thermo Fisher Scientific, and Virbac, among others. These companies are at the forefront of innovation, providing a wide array of diagnostic products, including PCR kits, immunoassays, and lateral flow devices. The market is characterized by significant R&D investments, strategic partnerships, and acquisitions aimed at expanding product portfolios and geographic reach. Companies are focusing on improving diagnostic accuracy, developing faster testing solutions, and catering to emerging diseases in poultry.
As the market continues to grow, competition is intensifying, with both established players and newer entrants striving to capture market share. Key trends such as the integration of digital platforms for data analytics and automation of diagnostic processes are becoming prominent. As poultry farms increasingly rely on data-driven solutions for disease management, companies that can offer integrated, scalable, and cost-effective diagnostic systems are likely to dominate the market in the coming years.
Report Features |
Description |
Market Size (2023) |
USD 740.5 Million |
Forecasted Value (2030) |
USD 1035.5 Million |
CAGR (2024 – 2030) |
4.9% |
Base Year for Estimation |
2023 |
Historic Year |
2022 |
Forecast Period |
2024 – 2030 |
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
Segments Covered |
Poultry Diagnostics Market By Product Type (Immunoassays, PCR Kits, Lateral Flow Devices, ELISA), By Disease Type (Avian Influenza, Infectious Bronchitis, Newcastle Disease, Salmonella Infections, Marek’s Disease, Coccidiosis), By Diagnostic Method (Serological Tests, Molecular Diagnostic Methods, Bacteriological Tests), By End-User (Poultry Farms, Diagnostic Laboratories, Government & Regulatory Bodies, Research Institutes) |
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
Major Companies |
Becton, Dickinson and Company (BD), Biolargo Inc., Boehringer Ingelheim International GmbH, Fisher Scientific, Hygiena LLC, IDEXX Laboratories, Inc., MSD Animal Health, QIAGEN N.V., Randox Laboratories, Roche Diagnostics, Thermo Fisher Scientific, Thermo Fisher Scientific Inc., Veta Diagnostics, Virbac, Zoetis Inc. |
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
1. Introduction |
1.1. Market Definition |
1.2. Scope of the Study |
1.3. Research Assumptions |
1.4. Study Limitations |
2. Research Methodology |
2.1. Research Approach |
2.1.1. Top-Down Method |
2.1.2. Bottom-Up Method |
2.1.3. Factor Impact Analysis |
2.2. Insights & Data Collection Process |
2.2.1. Secondary Research |
2.2.2. Primary Research |
2.3. Data Mining Process |
2.3.1. Data Analysis |
2.3.2. Data Validation and Revalidation |
2.3.3. Data Triangulation |
3. Executive Summary |
3.1. Major Markets & Segments |
3.2. Highest Growing Regions and Respective Countries |
3.3. Impact of Growth Drivers & Inhibitors |
3.4. Regulatory Overview by Country |
4. Poultry Diagnostics Market, by Type (Market Size & Forecast: USD Million, 2022 – 2030) |
4.1. Soybeans |
4.2. Sunflower Seeds |
4.3. Canola |
4.4. Cottonseeds |
4.5. Peanuts |
4.6. Rapeseed |
4.7. Others |
5. Poultry Diagnostics Market, by Form (Market Size & Forecast: USD Million, 2022 – 2030) |
5.1. Whole Seeds |
5.2. Meal |
5.3. Oil |
5.4. Others |
6. Poultry Diagnostics Market, by Application (Market Size & Forecast: USD Million, 2022 – 2030) |
6.1. Food & Beverages |
6.2. Animal Feed |
6.3. Biofuels |
6.4. Industrial Uses |
6.5. Cosmetics & Personal Care |
6.6. Pharmaceuticals |
6.7. Others |
7. Poultry Diagnostics Market, by End-User Industry (Market Size & Forecast: USD Million, 2022 – 2030) |
7.1. Food Processing |
7.2. Agriculture & Animal Feed |
7.3. Biofuel Industry |
7.4. Personal Care & Cosmetics |
7.5. Pharmaceuticals |
7.6. Others |
8. Regional Analysis (Market Size & Forecast: USD Million, 2022 – 2030) |
8.1. Regional Overview |
8.2. North America |
8.2.1. Regional Trends & Growth Drivers |
8.2.2. Barriers & Challenges |
8.2.3. Opportunities |
8.2.4. Factor Impact Analysis |
8.2.5. Technology Trends |
8.2.6. North America Poultry Diagnostics Market, by Type |
8.2.7. North America Poultry Diagnostics Market, by Form |
8.2.8. North America Poultry Diagnostics Market, by Application |
8.2.9. North America Poultry Diagnostics Market, by |
8.2.10. By Country |
8.2.10.1. US |
8.2.10.1.1. US Poultry Diagnostics Market, by Type |
8.2.10.1.2. US Poultry Diagnostics Market, by Form |
8.2.10.1.3. US Poultry Diagnostics Market, by Application |
8.2.10.1.4. US Poultry Diagnostics Market, by |
8.2.10.2. Canada |
8.2.10.3. Mexico |
*Similar segmentation will be provided for each region and country |
8.3. Europe |
8.4. Asia-Pacific |
8.5. Latin America |
8.6. Middle East & Africa |
9. Competitive Landscape |
9.1. Overview of the Key Players |
9.2. Competitive Ecosystem |
9.2.1. Level of Fragmentation |
9.2.2. Market Consolidation |
9.2.3. Product Innovation |
9.3. Company Share Analysis |
9.4. Company Benchmarking Matrix |
9.4.1. Strategic Overview |
9.4.2. Product Innovations |
9.5. Start-up Ecosystem |
9.6. Strategic Competitive Insights/ Customer Imperatives |
9.7. ESG Matrix/ Sustainability Matrix |
9.8. Manufacturing Network |
9.8.1. Locations |
9.8.2. Supply Chain and Logistics |
9.8.3. Product Flexibility/Customization |
9.8.4. Digital Transformation and Connectivity |
9.8.5. Environmental and Regulatory Compliance |
9.9. Technology Readiness Level Matrix |
9.10. Technology Maturity Curve |
9.11. Buying Criteria |
10. Company Profiles |
10.1. Becton, Dickinson and Company (BD) |
10.1.1. Company Overview |
10.1.2. Company Financials |
10.1.3. Product/Service Portfolio |
10.1.4. Recent Developments |
10.1.5. IMR Analysis |
*Similar information will be provided for other companies |
10.2. Biolargo Inc. |
10.3. Boehringer Ingelheim International GmbH |
10.4. Fisher Scientific |
10.5. Hygiena LLC |
10.6. IDEXX Laboratories, Inc. |
10.7. MSD Animal Health |
10.8. QIAGEN N.V. |
10.9. Randox Laboratories |
10.10. Roche Diagnostics |
10.11. Thermo Fisher Scientific |
10.12. Thermo Fisher Scientific Inc. |
10.13. Veta Diagnostics |
10.14. Virbac |
10.15. Zoetis Inc. |
11. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Poultry Diagnostics Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Poultry Diagnostics Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the Poultry Diagnostics ecosystem. The primary research objectives included:
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Poultry Diagnostics Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.